Trace Neuroscience Launches with $101M to Target ALS and Neurodegenerative Diseases
Key Highlights $101M Series A funding led by Third Rock Ventures and others, supporting ALS and neurodegenerative therapies. UNC13A-focused…
Browsing Tag
Third Rock Ventures
7 posts
Terremoto Biosciences Appoints Charles Baum as CEO
Key Highlights Charles Baum, M.D., Ph.D., appointed as Chief Executive Officer of Terremoto Biosciences. Baum succeeds Peter Thompson,…
EveryONE Medicines Appoints New CEO and Chairman
Key Highlights Kent Rogers appointed as CEO and Josh Ofman, MD, MSHS as Chairman. First biotech company dedicated to personalized genetic medicines.…
Marea Therapeutics Launches with $190 Million to Transform Cardiometabolic Disease Treatment
Key Highlights $190 million in Series A and B financings led by top investors. MAR001 targets ANGPTL4 to…
Element Science Appoints Lee Smith Jr. as Head of Commercial
Key Highlights Element Science appoints Lee Smith Jr. as Head of Commercial. Smith brings nearly 20 years of…
Asher Bio Secures $55M in Series C Funding for Cancer Therapy
Key Highlights $55 million raised in Series C financing to advance AB248, a novel cancer immunotherapy. New investors include AstraZeneca…
PureTech Health Advances Strategic Initiatives, Launches Seaport Therapeutics
Key Highlights Seaport Therapeutics launches with $100M in Series A financing to develop neuropsychiatric medicines. Leadership Transition: Daphne Zohar steps…